News & Updates
Filter by Specialty:

Novel antireflux device shows potential for treatment of PPI-refractory GERD
11 Jul 2024
byStephen Padilla
Patients suffering from gastroesophageal reflux disease (GERD) and ineffective esophageal motility (IEM) may benefit from the novel RefluxStop device implantation, a safe and minimally invasive technology that offers potential benefits, a study has shown.
Novel antireflux device shows potential for treatment of PPI-refractory GERD
11 Jul 2024
Glecaprevir/pibrentasvir shows favourable efficacy signals for paediatric HCV
10 Jul 2024
byAudrey Abella
Findings from the ongoing POLAC project demonstrate that treatment with the pangenotypic regimen comprising glecaprevir/pibrentasvir (GLE/PIB) for 8 weeks is highly effective against chronic hepatitis C virus (HCV) infection in children and adolescents. This regimen also showed a good safety profile.